Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Diabetologia
Published in: Diabetologia 6/2008

01-06-2008 | Article

Human retinal pigment epithelium proteome changes in early diabetes

Authors: A. Decanini, P. R. Karunadharma, C. L. Nordgaard, X. Feng, T. W. Olsen, D. A. Ferrington

Published in: Diabetologia | Issue 6/2008

Login to get access

Abstract

Aims/hypothesis

Diabetic retinopathy is the most common complication of diabetes and a leading cause of blindness among working-age adults. Anatomical and functional changes occur in the retina and retinal pigment epithelium (RPE) prior to clinical symptoms of the disease. However, the molecular mechanisms responsible for these early changes, particularly in the RPE, remain unclear. To begin defining the molecular changes associated with pre-retinopathic diabetes, we conducted a comparative proteomics study of human donor RPE.

Methods

The RPE was dissected from diabetic human donor eyes with no clinically apparent diabetic retinopathy (n = 6) and from eyes of age-matched control donors (n = 17). Soluble proteins were separated based upon their mass and charge using two-dimensional (2-D) gel electrophoresis. Protein spots were visualised with a fluorescent dye and spot densities were compared between diabetic and control gels. Proteins from spots with significant disease-related changes in density were identified using mass spectrometry.

Results

Analysis of 325 spots on 2-D gels identified 31 spots that were either up- or downregulated relative to those from age-matched control donors. The protein identity of 18 spots was determined by mass spectrometry. A majority of altered proteins belonged to two major functional groups, metabolism and chaperones, while other affected categories included protein degradation, synthesis and transport, oxidoreductases, cytoskeletal structure and retinoid metabolism.

Conclusions/interpretation

Changes identified in the RPE proteome of pre-retinopathic diabetic donor eyes compared with age-matched controls suggest specific cellular alterations that may contribute to diabetic retinopathy. Defining the pre-retinopathic changes affecting the RPE could provide important insight into the molecular events that lead to this disease.
Literature
1.
2.
Klein R, Klein BE, Moss SE, Cruickshanks KJ (1998) The Wisconsin epidemiologic study of diabetic retinopathy: XVII The 14-year incidence and progression of diabetic retinopathy and associated risk factors in type 1 diabetes. Ophthalmology 105:1801–1815PubMedCrossRef
3.
Antonetti DA, Barber AJ, Bronson SK et al (2006) Diabetic retinopathy: seeing beyond glucose-induced microvascular disease. Diabetes 55:2401–2411PubMedCrossRef
4.
Park SH, Park JW, Park SJ et al (2003) Apoptotic death of photoreceptors in the streptozotocin-induced diabetic rat retina. Diabetologia 46:1260–1268PubMedCrossRef
5.
Aizu Y, Oyanagi K, Hu J, Nakagawa H (2002) Degeneration of retinal neuronal processes and pigment epithelium in the early stage of the streptozotocin-diabetic rats. Neuropathology 22:161–170PubMedCrossRef
6.
Phipps JA, Fletcher EL, Vingrys AJ (2004) Paired-flash identification of rod and cone dysfunction in the diabetic rat. Invest Ophthalmol Vis Sci 45:4592–4600PubMedCrossRef
7.
Bensaoula T, Ottlecz A (2001) Biochemical and ultrastructural studies in the neural retina and retinal pigment epithelium of STZ-diabetic rats: effect of captopril. J Ocul Pharmacol Ther 17:573–586PubMedCrossRef
8.
Ramsey DJ, Ripps H, Qian H (2006) An electrophysiological study of retinal function in the diabetic female rat. Invest Ophthalmol Vis Sci 47:5116–5124PubMedCrossRef
9.
Klemp K, Larsen M, Sander B, Vaag A, Brockhoff PB, Lund-Andersen H (2004) Effect of short-term hyperglycemia on multifocal electroretinogram in diabetic patients without retinopathy. Invest Ophthalmol Vis Sci 45:3812–3819PubMedCrossRef
10.
Steinberg RH (1985) Interactions between the retinal pigment epithelium and the neural retina. Doc Ophthalmol 60:327–346PubMedCrossRef
11.
Young TA, Wang H, Munk S et al (2005) Vascular endothelial growth factor expression and secretion by retinal pigment epithelial cells in high glucose and hypoxia is protein kinase C-dependent. Exp Eye Res 80:651–662PubMedCrossRef
12.
Foulds WS (1990) The choroidal circulation and retinal metabolism—an overview. Eye 4:243–248PubMed
13.
Quin GG, Len AC, Billson FA, Gillies MC (2007) Proteome map of normal rat retina and comparison with the proteome of diabetic rat retina: new insight in the pathogenesis of diabetic retinopathy. Proteomics 7:2636–2650PubMedCrossRef
14.
Wang YD, Wu JD, Jiang ZL et al (2007) Comparative proteome analysis of neural retinas from type 2 diabetic rats by two-dimensional electrophoresis. Curr Eye Res 32:891–901PubMedCrossRef
15.
Nordgaard CL, Berg KM, Kapphahn RJ et al (2006) Proteomics of the retinal pigment epithelium reveals altered protein expression at progressive stages of age-related macular degeneration. Invest Ophthalmol Vis Sci 47:815–822PubMedCrossRef
16.
Ethen CM, Reilly C, Feng X, Olsen TW, Ferrington DA (2006) The proteome of central and peripheral retina with progression of age-related macular degeneration. Invest Ophthalmol Vis Sci 47:2280–2290PubMedCrossRef
17.
Kapphahn RJ, Ethen CM, Peters EA, Higgins L, Ferrington DA (2003) Modified alpha A crystallin in the retina: altered expression and truncation with aging. Biochemistry 42:15310–15325PubMedCrossRef
18.
Olsen TW, Feng X (2004) The Minnesota Grading System of eye bank eyes for age-related macular degeneration. Invest Ophthalmol Vis Sci 45:4484–4490PubMedCrossRef
19.
Harris WA, Janecki DJ, Reilly JP (2002) Use of matrix clusters and trypsin autolysis fragments as mass calibrants in matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. Rapid Commun Mass Spectrom 16:1714–1722PubMedCrossRef
20.
Hoppe G, O'Neil J, Hoff HF, Sears J (2004) Products of lipid peroxidation induce missorting of the principal lysosomal protease in retinal pigment epithelium. Biochim Biophys Acta 1689:33–41PubMed
21.
Witmer AN, Vrensen GF, Van Noorden CJ, Schlingemann RO (2003) Vascular endothelial growth factors and angiogenesis in eye disease. Prog Retin Eye Res 22:1–29PubMedCrossRef
22.
Yamane K, Minamoto A, Yamashita H et al (2003) Proteome analysis of human vitreous proteins. Mol Cell Proteomics 2:1177–1187PubMedCrossRef
23.
West KA, Yan L, Shadrach K et al (2003) Protein database, human retinal pigment epithelium. Mol Cell Proteomics 2:37–49PubMedCrossRef
24.
Ouchi M, West K, Crabb JW, Kinoshita S, Kamei M (2005) Proteomic analysis of vitreous from diabetic macular edema. Exp Eye Res 81:176–182PubMedCrossRef
25.
Patel JI, Tombran-Tink J, Hykin PG, Gregor ZJ, Cree IA (2006) Vitreous and aqueous concentrations of proangiogenic, antiangiogenic factors and other cytokines in diabetic retinopathy patients with macular edema: implications for structural differences in macular profiles. Exp Eye Res 82:798–806PubMedCrossRef
26.
Nakanishi T, Koyama R, Ikeda T, Shimizu A (2002) Catalogue of soluble proteins in the human vitreous humor: comparison between diabetic retinopathy and macular hole. J Chromatogr B Analyt Technol Biomed Life Sci 776:89–100PubMedCrossRef
27.
Bishop PN, Takanosu M, Le Goff M, Mayne R (2002) The role of the posterior ciliary body in the biosynthesis of vitreous humour. Eye 16:454–460PubMedCrossRef
28.
Crowther GJ, Milstein JM, Jubrias SA, Kushmerick MJ, Gronka RK, Conley KE (2003) Altered energetic properties in skeletal muscle of men with well-controlled insulin-dependent (type 1) diabetes. Am J Physiol Endocrinol Metab 284:E655–E662PubMed
29.
Simoneau JA, Kelley DE (1997) Altered glycolytic and oxidative capacities of skeletal muscle contribute to insulin resistance in NIDDM. J Appl Physiol 83:166–171PubMed
30.
Stanley WC, Lopaschuk GD, McCormack JG (1997) Regulation of energy substrate metabolism in the diabetic heart. Cardiovasc Res 34:25–33PubMedCrossRef
31.
McLean MP, Billheimer JT, Warden KJ, Irby RB (1995) Differential expression of hepatic sterol carrier proteins in the streptozotocin-treated diabetic rat. Endocrinology 136:3360–3368PubMedCrossRef
32.
Tessari P, Puricelli L, Iori E et al (2007) Altered chaperone and protein turnover regulators expression in cultured skin fibroblasts from type 1 diabetes mellitus with nephropathy. J Proteome Res 6:976–986PubMedCrossRef
33.
Puricelli L, Iori E, Millioni R et al (2006) Proteome analysis of cultured fibroblasts from type 1 diabetic patients and normal subjects. J Clin Endocrinol Metab 91:3507–3514PubMedCrossRef
34.
Ola MS, Berkich DA, Xu Y et al (2006) Analysis of glucose metabolism in diabetic rat retinas. Am J Physiol Endocrinol Metab 290:E1057–E1067PubMedCrossRef
35.
36.
Yao Y, Zhou Y, Wang C (1997) Both the isomerase and chaperone activities of protein disulfide isomerase are required for the reactivation of reduced and denatured acidic phospholipase A2. Embo J 16:651–658PubMedCrossRef
37.
38.
Nozaki J, Kubota H, Yoshida H et al (2004) The endoplasmic reticulum stress response is stimulated through the continuous activation of transcription factors ATF6 and XBP1 in Ins2+/Akita pancreatic beta cells. Genes Cells 9:261–270PubMedCrossRef
39.
Laybutt DR, Preston AM, Akerfeldt MC et al (2007) Endoplasmic reticulum stress contributes to beta cell apoptosis in type 2 diabetes. Diabetologia 50:752–763PubMedCrossRef
40.
Ohta S, Ohsawa I (2006) Dysfunction of mitochondria and oxidative stress in the pathogenesis of Alzheimer’s disease: on defects in the cytochrome c oxidase complex and aldehyde detoxification. J Alzheimers Dis 9:155–166PubMed
41.
van Reyk DM, Gillies MC, Davies MJ (2003) The retina: oxidative stress and diabetes. Redox Rep 8:187–192PubMedCrossRef
42.
Ellis EM (2007) Reactive carbonyls and oxidative stress: potential for therapeutic intervention. Pharmacol Ther 115:13–24PubMedCrossRef
43.
Dhalla NS, Liu X, Panagia V, Takeda N (1998) Subcellular remodeling and heart dysfunction in chronic diabetes. Cardiovasc Res 40:239–247PubMedCrossRef
44.
McLean WG (1997) The role of axonal cytoskeleton in diabetic neuropathy. Neurochem Res 22:951–956PubMedCrossRef
45.
Murata C, Taniyama M, Kuriyama S et al (2004) Meta-analysis of three diabetes population studies: association of inactive ALDH2 genotype with maternal inheritance of diabetes. Diabetes Res Clin Pract 66(Suppl 1):S145–S147PubMedCrossRef
46.
Wadham C, Parker A, Wang L, Xia P (2007) High glucose attenuates protein S-nitrosylation in endothelial cells: role of oxidative stress. Diabetes 56:2715–2721PubMedCrossRef
47.
Witek B, Krol T, Kolataj A, Ochwanowska E, Stanislawska I, Slewa A (2001) The insulin, glucose and cholesterol level and activity of lysosomal enzymes in the course of the model alloxan diabetes. Neuro Endocrinol Lett 22:238–242PubMed
48.
Sreekumar R, Halvatsiotis P, Schimke JC, Nair KS (2002) Gene expression profile in skeletal muscle of type 2 diabetes and the effect of insulin treatment. Diabetes 51:1913–1920PubMedCrossRef
49.
Yokoyama T, Yamane K, Minamoto A et al (2006) High glucose concentration induces elevated expression of anti-oxidant and proteolytic enzymes in cultured human retinal pigment epithelial cells. Exp Eye Res 83:602–609PubMedCrossRef
50.
Turko IV, Marcondes S, Murad F (2001) Diabetes-associated nitration of tyrosine and inactivation of succinyl-CoA:3-oxoacid CoA-transferase. Am J Physiol Heart Circ Physiol 281:H2289–H2294PubMed
Metadata
Title
Human retinal pigment epithelium proteome changes in early diabetes
Authors
A. Decanini
P. R. Karunadharma
C. L. Nordgaard
X. Feng
T. W. Olsen
D. A. Ferrington
Publication date
01-06-2008
Publisher
Springer-Verlag
Published in
Diabetologia / Issue 6/2008
Print ISSN: 0012-186X
Electronic ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-008-0991-2

Other articles of this Issue 6/2008

Diabetologia 6/2008 Go to the issue

Article

Beta cell chromogranin B is partially segregated in distinct granules and can be released separately from insulin in response to stimulation

Article

Increased osteoclastic activity in acute Charcot’s osteoarthopathy: the role of receptor activator of nuclear factor-kappaB ligand

Article

Glucose lowers the threshold for human aortic vascular smooth muscle cell migration: inhibition by protein phosphatase-2A

Research Letter

Reconstituted HDL infusion restores endothelial function in patients with type 2 diabetes mellitus

Article

A potential role for skeletal muscle caveolin-1 as an insulin sensitivity modulator in ageing-dependent non-obese type 2 diabetes: studies in a new mouse model

Short Communication

The relationship between admission blood glucose levels and hospital mortality
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits